Recent News - Cannabis


Intellectual Property Team Clears Challenge For Fees
January 20, 2021 | Intellectual Property

Greg Miller, Nancy Del Pizzo and J’Naia Boyd overcame a motion for reconsideration of a federal magistrate judge’s report and recommendations where defendants had sought compensation from our clients in the six figures in this trademark action. Our Intellectual Property team convinced the district judge that the case is not “exceptional” under the Lanham Act,

Read More
Share this article:
Ullman to be Panelist at Dietary Supplement (GMP) Compliance Virtual Seminar
January 13, 2021 | Health Services

Marc Ullman will be a panelist at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Virtual Seminar.

The seminar will be held on February 2, 4, 9 and 11 from 11:00am to 4:00pm.

In these unprecedented times, the dietary supplement industry is playing an essential role for the U.S. consumer. Never before have more questions

Read More
Share this article:
Real Estate Transactions for November
December 8, 2020 | Real Estate, Zoning & Land Use

On November 3, 2020, Yaron Kornblum and Marie Landsman represented the borrowers, three tenants in common entities, in a refinance with Andrews Federal Credit Union with a loan amount of $6 million for a property located at 440 and 450 Waverly Avenue, Patchogue, NY, a medical and professional office building consisting of 20 commercial spaces.

Read More
Share this article:
Ullman Speaks with NutraIngredients-USA
August 26, 2020 | Cannabis | Health Services

Marc Ullman was quoted in a NutraIngredients-USA article, “AHPA event aims to guide CBD industry.”

The article discusses how products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers.

Click here to read the full article.

Read More
Share this article:
Ullman Quoted in NutraIngredients USA
August 21, 2020 | Cannabis | Health Services

Marc Ullman was quoted in a NutraIngredients USA article, “Upcoming event aims to help fill regulatory holes in hemp/CBD industry.”

The article discusses how CBD firms are often unprepared for the regulatory compliance side of operating a dietary supplement firm. The upcoming event that is being discussed in the article looks to assist with that.

Read More
Share this article:
Ullman to Present at Virtual Hemp-CBD Supplement Congress
July 20, 2020 | Health Services | Cannabis | Compliance Investigations & White Collar

On August 27, Marc Ullman will be presenting at the American Herbal Products Association (AHPA) Hemp-CBD Supplement Virtual Congress. The seminar will provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market.

Click here to register.

Read More
Share this article:
Ullman Cited in Article on CBD in Foods and Beverages
June 15, 2020 | Cannabis | Health Services

Marc Ullman was cited in Nutritional Outlook’s article, “High anxiety: Will CBD ever be legal in foods and beverages?”

The article discusses whether or not the FDA will ever approve the use of CBD in foods and beverages. Currently, it is not a lawful ingredient. Ullman provided advice on the procedures necessary to prove the

Read More
Share this article:
Ullman Lends Perspective on FDA Warning Letter
June 4, 2020 | Cannabis | Compliance Investigations & White Collar

Marc Ullman was quoted in a Nutraingredients-USA.com article entitled “Warning letter cites CBD’s regulatory status as leading issue.”

The Food and Drug Administration sent a warning letter to a supplement manufacturer regarding various failures in good manufacturing practice (GMP). For the first time, however, the letter cited the health claims made about CBD as the first

Read More
Share this article:
Shapiro Speaks to NYSBA Food, Drug and Cosmetic Law Section
January 29, 2020 | Cannabis | Compliance Investigations & White Collar

On Thursday, January 30, 2020, Steven Shapiro will present to the New York State Bar Association’s Food, Drug and Cosmetic Law Section as part of its Off-Label Promotion Update. His presentation is entitled “Promotion of CBD following Epidiolex for Rx, OTC drugs and other products.

For information and to register, click here.

Read More
Share this article:
Ullman’s Op-Ed on CBD Appears in Long Island Business News
January 29, 2020 | Compliance Investigations & White Collar | Cannabis

On January 29, 2020, Marc Ullman’s opinion piece, “FDA’s lack of CBD guidance is a disservice to Long Island firms,” appeared in Long Island Business News.

Marc notes that an exploding market for CBD products has created a conundrum for companies wishing to cash in. Either they obey FDA’s regulations and lose out, or they break

Read More
Share this article:
Previous PageNext Page

Get legal updates and news delivered to your inbox